|
HSDL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.65678581964812E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.645720E-02 |
| Stage1-vs-Stage3 |
5.917400E-01 |
| Stage1-vs-Stage4 |
2.024900E-04 |
| Stage2-vs-Stage3 |
9.535300E-03 |
| Stage2-vs-Stage4 |
3.77420000000628E-05 |
| Stage3-vs-Stage4 |
1.479620E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
9.78059855327729E-11 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
4.183000E-01 |
| Caucasian-vs-Asian |
2.640400E-01 |
| AfricanAmerican-vs-Asian |
2.215000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.882000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.43200000005217E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.692800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.436800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.094400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.252400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.491200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.546400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.002400E-02 |
| Classical-VS-Follicular |
3.79030000000613E-05 |
| Classical-VS-Other |
7.356000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.38779999994776E-07 |
| Tall-VS-Other |
5.905200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.068160E-01 |
| Follicular-VS-Normal |
1.63491442606301E-12 |
| Other-VS-Normal |
9.61269952526322E-11 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.163820E-04 |
|
|
